The American Association for Cancer Research (AACR) recently held its annual meeting, which kicked off with the usual opening ceremony. However, what stood out was AACR CEO Margaret Foti’s closing remarks, which took a strong stance against the Trump administration’s actions on science and health policy in the first hundred days.
Foti criticized the administration for imposing major funding freezes on leading research institutions nationwide and implementing executive orders that could potentially harm the National Institutes of Health (NIH). She emphasized AACR’s longstanding advocacy efforts in Washington for cancer research, which have involved organizing congressional briefings, demonstrations, and coalition-building to secure more funding for cancer science.
In response to the concerning developments in science and health policy, AACR is planning demonstrations and events that aim to mobilize representatives and scientists across the country. Foti encouraged attendees at the annual meeting to actively participate in these initiatives to advocate for the importance of cancer research.
The article goes on to mention that further details and in-depth analysis are available exclusively to STAT+ subscribers. It provides a preview of the restricted content and prompts readers to subscribe to access the full article, along with additional features like newsletters, premium events, and news alerts.
Overall, the AACR annual meeting served as a platform for highlighting the crucial role of cancer research and for voicing concerns about potential threats to scientific progress and public health. Foti’s bold condemnation of the administration’s policies underscores the importance of continued advocacy and collaboration within the scientific community to safeguard research funding and advance cancer science.
